185 related articles for article (PubMed ID: 28356286)
1. Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation.
Park JH; Jang HR; Kim DH; Kwon GY; Lee JE; Huh W; Choi SJ; Oh W; Oh HY; Kim YG
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F984-F996. PubMed ID: 28356286
[TBL] [Abstract][Full Text] [Related]
2. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
5. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
[TBL] [Abstract][Full Text] [Related]
7. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury.
Guo Q; Wang J
Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):168-172. PubMed ID: 29355065
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury.
Tsuda H; Yamahara K; Otani K; Okumi M; Yazawa K; Kaimori JY; Taguchi A; Kangawa K; Ikeda T; Takahara S; Isaka Y
Cell Transplant; 2014; 23(7):889-99. PubMed ID: 23562186
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor.
Kim H; Lee H; Lee G; Jang H; Kim SS; Yoon H; Kang GH; Hwang DS; Kim SK; Chung HS; Bae H
Kidney Int; 2015 Sep; 88(3):550-9. PubMed ID: 25993317
[TBL] [Abstract][Full Text] [Related]
10. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.
Yuan L; Wu MJ; Sun HY; Xiong J; Zhang Y; Liu CY; Fu LL; Liu DM; Liu HQ; Mei CL
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F207-18. PubMed ID: 20943766
[TBL] [Abstract][Full Text] [Related]
11. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
[TBL] [Abstract][Full Text] [Related]
13. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
14. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
16. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.
Burks SR; Nguyen BA; Tebebi PA; Kim SJ; Bresler MN; Ziadloo A; Street JM; Yuen PS; Star RA; Frank JA
Stem Cells; 2015 Apr; 33(4):1241-53. PubMed ID: 25640064
[TBL] [Abstract][Full Text] [Related]
17. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
Park JH; Hwang I; Hwang SH; Han H; Ha H
Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
